Key facts
- · Type: Amendment first sale 2022-11-10 · Amount sold: $1.70M · Total offering: $3M · SEC filing
- · Type: New offering first sale 2024-02-06 · Amount sold: $200K · Total offering: $400K · SEC filing
- · Type: New offering first sale 2022-11-10 · Amount sold: $600K · Total offering: $1M · SEC filing
Is PathCision Medicine, Inc. a real, registered company?
PathCision Medicine, Inc. is a registered filer with the SEC (CIK 1959064) and has filed since 2022-12-30. 3 filings are on record, the latest on 2026-02-05.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
How much has PathCision Medicine, Inc. raised?
Its new offerings report $800K sold across 2 offerings, as its own filings state.
Run the free check on PathCision Medicine, Inc. →
WATERTOWN, MASSACHUSETTS
2022
Biotechnology
3
$800K
Every filing
| Filed | Type | Amount sold | Total offering | Records |
|---|---|---|---|---|
| 2026-02-05 | Amendment first sale 2022-11-10 | $1.70M | $3M | SEC filing |
| 2024-02-21 | New offering first sale 2024-02-06 | $200K | $400K | SEC filing |
| 2022-12-30 | New offering first sale 2022-11-10 | $600K | $1M | details · SEC filing |
Keep reading
More on PathCision Medicine, Inc. and the records around it.
PathCision Medicine, Inc. elsewhere on the record
- Form D filing Dec 2022
Watch PathCision Medicine, Inc.
Get an email when PathCision Medicine, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
What do you want to do with PathCision Medicine, Inc.?
Who to contact
- Hui-Hsuan Wang — Executive Officer, Director
- Yang Lee — Executive Officer, Director
- Round: Form D/A (amended) filed 2026-02-05
- Amount sold: $1.70M
- Industry: Biotechnology
- Founded: 2022
- Based: WATERTOWN, MASSACHUSETTS
People listed
- Hui-Hsuan Wang — Executive Officer, Director
- Yang Lee — Executive Officer, Director
- Filing: Form D/A (amended) filed 2026-02-05
- Amount sold: $1.70M
- Industry group: Biotechnology
- Year formed: 2022
- Based: WATERTOWN, MASSACHUSETTS
- Entity type: Corporation
We'll show it in your MentionFox inbox when PathCision Medicine, Inc. raises, hires or launches. No email unless you switch it on.
Watch PathCision Medicine, Inc. →Want the whole picture on PathCision Medicine, Inc.?
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on PathCision Medicine, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on PathCision Medicine, Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
5 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
How the total is counted: the amount sold on each new offering, added together. Amendments are left out, because an amendment restates an offering already counted. A filing whose figures have not been read yet shows a dash and adds nothing.
Every figure here is read from PathCision Medicine, Inc.'s own filings with the SEC. The people those filings name are on the team page.